CATCH-UP: NCI ETCTN Pittsburgh Cancer Consortium (PCC)

追赶：NCI ETCTN 匹兹堡癌症联盟 (PCC)

基本信息

批准号：
10677058
负责人：
Jan Hendrik Beumer
金额：
$ 40万
依托单位：
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-03-25 至 2023-02-28
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10677058
关键词：
Address Adverse event Appointment Asian California Cancer Center Catchment Area Clinical Clinical Investigator Clinical Nursing Research Clinical Pharmacists Clinical Research Clinical Research Associate Clinical Trials Network Competence Comprehensive Cancer Center Cost Sharing Data Data Reporting Development Disease Early Therapeutic-Clinical Trials Network Enrollment Environment Equipment and supply inventories Family Goals Human Resources Investigational Drugs Investigational Therapies Latino Lead Leadership Malignant Neoplasms Network Infrastructure Outcome Patients Peer Review Performance Pharmaceutical Preparations Phase Process Reporting Research Personnel Resources Site Training Underserved Population United States National Institutes of Health Universities Work adverse outcome base cancer care cancer clinical trial early phase clinical trial experience meetings member minority patient novel strategies patient population programs racial and ethnic success targeted cancer therapy underserved area

项目摘要

ABSTRACT This application is being submitted to request the addition of an Affiliated Organization(s) to the Early Therapeutics Clinical Trial Network (ETCTN) UM1 Lead Academic Organization. The Chao Family Comprehensive Cancer Center (CFCCC) of the University of California, Irvine (UCI) has demonstrated to be a well performing site in the Create Access to Targeted Cancer Therapy for Underserved Populations (CATCH-UP) program, enrolling a total of 34 patients with nearly half (48%) coming from diverse patient populations (e.g. Latino, Asian and underserved areas). With the success of CFCCC’s participation in CATCH-UP, CFCCC will be integrated into the Pittsburgh Cancer Consortium (PCC), providing access for their patients to all ETCTN trials. The PCC will integrate CFCCC by providing regulatory support, data coordination and reporting of adverse events and outcomes on the studies led by UCI investigators. In addition, the PCC will support CFCCC through development of concepts and leadership in ETCTN trials. Conversely, CFCCC will use their experience and success in the CATCH-UP program to deploy best practices in underserved patient accrual in the PCC.

抽象的提交此申请是为了请求在早期计划中添加一个附属组织治疗临床试验网络 (ETCTN) UM1 领导学术组织。加州大学欧文分校 (UCI) 赵氏家族综合癌症中心 (CFCCC) 成为“Create Access”中表现良好的网站，证明可以为服务不足的地区提供靶向癌症治疗人群 (CATCH-UP) 计划，总共招募了 34 名患者，其中近一半 (48%) 来自不同背景随着 CFCCC 成功参与，患者人群（例如拉丁裔、亚洲人和服务欠缺地区）。 CATCH-UP、CFCCC 将并入匹兹堡癌症联盟 (PCC)，为他们提供访问权限参加所有 ETCTN 试验的患者。 PCC 将通过提供监管支持、数据协调和不良报告来整合 CFCC UCI 研究人员领导的研究的事件和结果此外，PCC 将通过以下方式支持 CFCCC。 CFCCC 将利用他们的经验和在线下 ETCTN 试验的概念和领导力。 CATCH-UP 计划的成功，旨在在 PCC 中部署服务不足的患者应计方面的最佳实践。